cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine peptide analytical standard 5-Amino-1MQ — 50mg | Variant:100mg

Name: cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine peptide analytical standard 5-Amino-1MQ — 50mg | Variant:100mg
Brand: gochinaprosper.cloud
SKU: 70139462193
Price: 26.04 USD
Availability: InStock
Rating: 4.5472 (30 reviews)

SKU: 70139462193

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Description

cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine peptide analytical standard 5-Amino-1MQ — 50mg | Variant:100mg

5-Amino-1MQ — 50mg | NNMT Inhibitor (NAD+ Axis) - VPeptide 5-Amino-1MQ Canada (50 mg): Ultra-Pure Metabolic Research Compound

PMID: 8 GoldmacherVSBourretLALevineBARasmussenRAPourshadiMLambertJMet al

peptide analytical standard

Variant:100mg

Where These Numbers Come From 5-Amino-1MQ dosing is entirely community-derived, extrapolated from preclinical animal research

Exchange/Return Notes